WHO ICTRP trial
Phase I Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Thyroid…
ChiCTR2500103991 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500103991 |
|---|---|
| Public title | Phase I Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Thyroid Cancer |
| Scientific title | A Multicenter, Open-Label, Single-Arm Phase I Clinical Study of 177Lu-CTR-FAPI Injection in the Treatment of Thyroid Cancer |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Thyroid cancer |
| Interventions | 177Lu-CTR-FAPI Treatment Group:177Lu-CTR-FAPI |
| Registration date | Jun 9, 2025 |
| Target size | 177Lu-CTR-FAPI Treatment Group:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: